Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
GLUCLOW_OTH
Extra metadata
List of similar endpoints to
Other blood glucose lowering drugs, excl. Insulins
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3305 | 1711 | 1594 |
| Unadjusted prevalence (%) | 1.27 | 1.16 | 1.41 |
| Mean age at first event (years) | 58.12 | 57.41 | 58.88 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.02 | 1.68 [1.24, 2.27] | 8.7e-4 | 384 |
| 15 years | 0.01 | 1.79 [1.38, 2.31] | 8.5e-6 | 283 |
| 5 years | 0.00 | 2.17 [1.66, 2.84] | 1.8e-8 | 91 |
| 1 year | 0.00 | 1.38 [0.72, 2.62] | 3.3e-1 | 10 |
Index endpoint: GLUCLOW_OTH – Other blood glucose lowering drugs, excl. Insulins
GWS hits:
before Other blood glucose lowering drugs, excl. Insulins
after Other blood glucose lowering drugs, excl. Insulins
Loading survival analyses plot
Loading survival analyses table